Navigation Links
Top 12 Pioneer Awards for seminal work in gene and cell therapy selected by blue ribbon panel
Date:11/25/2013

New Rochelle, NY, November 25, 2013 The peer-reviewed journal Human Gene Therapy will celebrate its 25th anniversary in 2014. The Journal will commemorate its silver anniversary in several ways, including publishing a series of Perspectives by top Pioneers in the field of cell and gene therapy who will be featured in the 2014 issues of the Journal.

The leadership of Human Gene Therapy commissioned a blue ribbon panel of colleagues to identify the Pioneers. Human Gene Therapy, Human Gene Therapy Methods, and Human Gene Therapy Clinical Development are published by Mary Ann Liebert, Inc., publishers.

The charge to the Committee was to identify 12 scientists who have made seminal contributions to the field in the context of a career that has consistently contributed to cell and gene therapy research for an extended period of time. The committee defines a seminal contribution as a ground breaking clinical study or a basic/technical advance that has substantially influenced the direction and/or trajectory of translational research. In some instances the Pioneer award was shared amongst several scientists whose seminal work within a programmatic area could not be fairly singled out.

"Identifying the pioneers who have made current successes in gene therapy possible was a really interesting process. The committee agreed that a mixture of virologists, technologists and clinicians had made essential contributions," says Mary Collins, PhD, Chair of the Award Selection Committee.

The Pioneer Series Award Selection Committee was chaired by Dr. Mary Collins, MRC Centre for Medical Molecular Virology, University College London, with members Alessandro Aiuti, MD, PhD, Scientific Institute HS Raffaele, HSR-TIGET; Andrew H. Baker, PhD, Institute of Cardiovascular and Medical Sciences BHF Glasgow, Cardiovascular Research Centre, University of Glasgow; Manuel Grez, PhD, Georg-Speyer-Haus, Molecular Virology Lab; Philippe Moullier, MD, PhD, Institut de Recherche Thrapeutique, Universit de Nantes; Paul D. Robbins, PhD, The Scripps Research Institute; Robert M. Kotin, PhD, National Heart, Lung, & Blood Institute, National Institutes of Health; Luk H. Vandenberghe, PhD, Harvard Medical School, Schepens Eye Research Institute, Massachusetts Eye and Ear Infirmary; and Xiao Xiao, PhD, School of Pharmacy, University of North Carolina at Chapel Hill.

The Winners of the 12 Pioneer Series Awards are:

  • Robin R. Ali, PhD, UCL Institute of Ophthalmology;
    Jean Bennett, MD, PhD, Perelman School of Medicine, University of Pennsylvania; and
    William W. Hauswirth, PhD, University of Florida College of Medicine
    Nominated for: Gene therapy for eye disorders

  • Malcolm K. Brenner, MD, PhD, Baylor College of Medicine
    Nominated for: Cancer gene therapy using gene modified T cells

  • Frederic D. Bushman, PhD, Perelman School of Medicine, University of Pennsylvania; and
    Christof von Kalle, MD, PhD, National Center for Tumor Diseases, Heidelberg
    Nominated for: Vector integration and tumorigenesis

  • Marina Cavazzana, MD, PhD, Paris Descartes University; and
    Adrian J. Thrasher, MD, PhD, UCL Institute of Child Health
    Nominated for: Basic and clinical gene therapy for immunodeficiency disorders

  • Ronald G. Crystal, MD, Weill Cornell Medical College, Cornell University
    Nominated for: Adenoviral vectors/role in translation of gene therapy to clinic

  • Zelig Eshhar, PhD, Department of Immunology, The Weizmann Institute of Science; and
    Carl H. June, MD, Perelman School of Medicine, University of Pennsylvania
    Nominated for: CARs for cancer gene therapy/lentiviral gene therapy clinical trials

    Joseph C. Glorioso III, PhD, University of Pittsburgh, School of Medicine
    Nominated for: Development of HSV as a vector for gene therapy

  • Katherine A. High, MD, Children's Hospital of Philadelphia;
    Amit C. Nathwani, PhD, UCL Cancer Institute;
    Andrew M. Davidoff, MD, St. Jude Children's Research Hospital; and
    Arthur W. Nienhuis, MD, St. Jude Children's Research Hospital
    Nominated for: Basic and clinical gene therapy for haemophilia

  • A. Dusty Miller, PhD, Fred Hutchinson Cancer Research Center, University of Washington; and
    Richard C. Mulligan, PhD, Harvard Gene Therapy Initiative, Harvard Institute of Medicine
    Nominated for: Retroviral vectors

  • Luigi M. Naldini, MD, PhD, San Raffaele Telethon Institute for Gene Therapy
    Nominated for: Basic and clinical lentiviral vector development and translational gene therapy

  • R. Jude Samulski, PhD, Gene Therapy Center, University of North Carolina at Chapel Hill
    Nominated for: Basic AAV vector technology

  • James M. Wilson, MD, PhD, Gene Therapy Program, Perelman School of Medicine, University of Pennsylvania
    Nominated for: Basic and clinical AAV vector development


'/>"/>

Contact: Jennifer Quigley
jquigley@liebertpub.com
914-740-2100 x2149
Mary Ann Liebert, Inc./Genetic Engineering News
Source:Eurekalert  

Related biology news :

1. Biometrics Pioneer DERMALOG Awarded German Foreign Trade Prize
2. 2 online science video pioneers combine to form new iBiology.org
3. Pioneers in Alzheimers research: Research couple honored for its lifetime achievement
4. Oxfords Gero Miesenböck is awarded The Brain Prize 2013 for his pioneering work on optogenetics
5. Manchester patients take part in pioneering heart attack blood test trial
6. Pioneer in neural development honored with the Mortimer D. Sackler, M.D. Prize
7. Damon Runyon-Rachleff Innovation Awards granted for pioneering ideas in cancer research
8. UCSB researchers perform pioneering research on Type 2 diabetes
9. Pioneering researcher receives Heart Association Lifetime Achievement Award
10. Stanford bioengineer Christina Smolke wins NIH Directors Pioneer Award
11. 2 pioneering plant genomics efforts given a funding boost by National Science Foundation
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Top 12 Pioneer Awards for seminal work in gene and cell therapy selected by blue ribbon panel
(Date:3/11/2016)... Germany , March 11, 2016 http://www.apimages.com ... - Cross reference: Picture is available at AP Images ( http://www.apimages.com ... from DERMALOG will be used to produce the new refugee identity ... other biometric innovations, at CeBIT in Hanover ... scanner from DERMALOG will be used to produce the new refugee ...
(Date:3/9/2016)... 2016 This BCC Research report provides an ... RNA Sequencing (RNA Seq) market for the years 2015, ... and reagents, data analysis, and services. Use ... RNA-Sequencing market such as RNA-Sequencing tools and reagents, RNA-Sequencing ... affecting each segment and forecast their market growth, future ...
(Date:3/3/2016)... , March 3, 2016  FlexTech, a SEMI ... categories of Innovation, Research & Development, Leadership in Education, ... This is the 9 th year of the ... of companies and individuals from past years . ... on a pre-described set of criteria, by a panel ...
Breaking Biology News(10 mins):
(Date:5/2/2016)... (PRWEB) , ... May 02, 2016 , ... ... with its clients in mind, the fresh look and added functionality give the ... “Recent years have seen a dynamic shift in agriculture – from precision farming ...
(Date:4/29/2016)... , ... April 29, 2016 , ... ... personalized pain medicine, is excited to announce the launch of the Proove ... health studies, volunteerism, and education to promote the use of personalized medicine for ...
(Date:4/29/2016)... KY and San Diego, CA (PRWEB) , ... April 29, 2016 ... ... National Stem Cell Foundation (NSCF) to support the development of a patient-specific stem cell ... Dr. Andrés Bratt-Leal in the lab of Dr. Jeanne Loring at The Scripps Research ...
(Date:4/28/2016)... 2016 Q BioMed Inc. ... CEO  was featured in an article he wrote ... Fear To Tread: http://www.lifescienceleader.com/doc/accelerators-enter-when-vcs-fear-to-tread-0001 ... is an essential business journal for life science ... to Big Pharmas. Their content is designed to ...
Breaking Biology Technology: